ALOXI caps moll 500 mcg
7680629520016
CH-62952
A04AA05
01.09.0.
Reimbursement limitations:
ALOXI
Pour la prévention des nausées et vomissements associés aux chimiothérapies cytostatiques modérément émétisantes chez l’adulte.
1 / 3
google
Details
- Product number
- 6295201
- CPT
- -
- Packaging group
- 1
- Unit
- Kapsel(n)
- Composition
- palonosetronum 500 µg ut palonosetroni hydrochloridum, antiox.: E 320, excipiens pro capsula.
Articles (1)
Aloxi 500 Mikrogramm, Weichkapseln
Weichkapseln
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | ANTOX |
Reimbursement information
Public price
CHF 84.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2014
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 62952
- Drug name
- Aloxi, Weichkapseln
- Galenic form
- KAPWE
- ATC Code
- A04AA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/10/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALOXI caps moll 500 mcg
- Description (DE)
- ALOXI Weichkaps 500 mcg
- Market launch
- 28/10/2013
- Narcotic (BTM)
- No